SNY

SanofiC

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-20

View Chart

Peers tracked

U.S. public peers

Grade Position

In line

vs peer average

SNY vs peer average

63/100

SNY vs. peer average (C vs. D)

Grade spread

C 3 · D 6 · F 1

Graded peers loaded

Coverage

10 graded

100% of tracked

Peer overview

NVS is the first available peer comparator.

Novartis — large diversified pharma with comparable pipeline/regulatory exposure; useful benchmark for R&D cadence.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerNVSNovartis

SNY

Sanofi

NVS

Novartis

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Mixed

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs NVS

SNY / NVS

Grade Position

In line

SNY vs. peer average (C vs. D)

63/100

Momentum

NVS

Value

SNY

Sentiment

SNY

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs SNY

40/100

20/100

40/100

Vertex Pharmaceuticals Inc Common

60/100

Even

BMY

Bristol-Myers Squibb Co Common

40/100

NVS is the first peer returned for this comparison set.